Frederick J Brown

This inventor holds 17 USPTO granted patents and 1 published patent application, primarily in Heterocyclic Compounds. Top assignees: Ici Americas, Inc., Zeneca Limited. Active years: 1989-1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Frederick J Brown. Retrieved from https://idiyas.com/inventor/frederick-j-brown

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 17 (Patent Applications = 1)

% Patents Active = 100.0

Average Co-Inventor Count = 3.3

ph-index = 8

Forward Citations = 161(Granted Patents)

Location History:

Crewe, GB (1990)
Newark, DE (US) (1989 - 1997)

Company Filing History:

Years Active: 1989-1997

Loading Chart...

Areas of Expertise:

Benzoxazines

Asthma Treatment

Vasospastic Diseases

Heterocyclic Amides

Leukotriene Antagonists

Carbocyclic Compounds

Indazole Compounds

Carboxamide Derivatives

Pharmaceutical Compositions

Potassium Channel Mediators

Heterocyclic Carboxamides

Aliphatic Carboxamides

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5700798 - Methods for using benzoxazines for treating asthma (1997-12-23),

2. 5583152 - Method for treating vasospastic cardiovascular diseases heterocyclic (1996-12-10),

3. 5486515 - 2-fluoroalkyl-1,4-benzoxaxines as potassium channel mediators (1996-01-23),

4. 5440035 - Heterocyclic amide derivatives (1995-08-08),

5. 5391758 - Heterocyclic amide derivatives (1995-02-21),

6. 5338734 - Heterocyclic amide derivatives and pharmaceutical use thereof (1994-08-16),

7. 5234942 - Heterocyclic amides and leucotriene antagonistic use thereof (1993-08-10),

8. 5179112 - Heterocyclic amide derivatives and pharmaceutical use (1993-01-12),

9. 5095038 - Carbocyclic compounds useful as leukotriene antagonists (1992-03-10),

10. 5049576 - Carboxamide derivatives (1991-09-17),

11. 5030643 - Heterocyclic amide derivatives and use (1991-07-09),

12. 4997844 - Indazole compounds, pharmaceutical compositions and use (1991-03-05),

13. 4918094 - Carboxamide derivatives of indoles and leucotriene antagonizing use (1990-04-17),

14. 4898863 - Heterocyclic carboxamides (1990-02-06),

15. 4894386 - Aliphatic carboxamides (1990-01-16),

Title: **Frederick J. Brown: A Pioneer in Pharmaceutical Innovations**

Introduction

Frederick J. Brown, an esteemed inventor based in Newark, Delaware, has made significant contributions to the field of pharmaceuticals through his innovative research and development efforts. With a remarkable portfolio of 17 patents, he has focused primarily on creating effective treatments for various medical conditions, including asthma and cardiovascular diseases.

Latest Patents

Among his latest patents are groundbreaking methods for using benzoxazines to treat asthma. These compounds, which involve a complex structure detailed in the specification, serve as potassium channel openers and are important for managing urinary incontinence. Additionally, Brown has developed a method for treating vasospastic cardiovascular diseases, which encompasses novel amide derivatives of benzoheterocyclylalkanoic acids and related compounds. These innovations not only detail the formulations but also include pharmaceutical compositions and processes for preparing these influential compounds.

Career Highlights

Frederick J. Brown's career is distinguished by his involvement with prominent companies such as ICI Americas, Inc. and Zeneca Limited. His role in these organizations has been pivotal in advancing pharmaceutical innovation, driving research that ultimately leads to the development of effective medical treatments.

Collaborations

Throughout his career, Brown has worked alongside talented colleagues, including Ying K. Yee and Peter R. Bernstein. These collaborations have undoubtedly enhanced the creative and innovative processes behind his patents, fostering an environment where groundbreaking ideas can flourish.

Conclusion

Frederick J. Brown's dedication to advancing medical science through his inventive work is commendable. With a rich history of patents and a commitment to improving health outcomes, his contributions continue to pave the way for future innovations in the pharmaceutical industry.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent pending: